Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

Sabine D. Allard; Brenda De Keersmaecker; Anna L. de Goede; Esther J. Verschuren; Jeanette Koetsveld; Mariska L. Reedijk; Carolien Wylock; Annelies V. De Bel; Judith Vandeloo; Frank Pistoor; Carlo Heirman; Walter E.P. Beyer; Paul H.C. Eilers; Jurgen Corthals; Iman Padmos; Kris Thielemans; Albert D.M.E. Osterhaus; Patrick Lacor; Marchina E. van der Ende; Joeri L. Aerts; Carel A. van Baalen; Rob A. Gruters

doi:10.1016/j.clim.2013.11.001

Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

Sabine D. Allard, Brenda De Keersmaecker, Anna L. de Goede, Esther J. Verschuren, Jeanette Koetsveld, Mariska L. Reedijk, Carolien Wylock, Annelies V. De Bel, Judith Vandeloo, Frank Pistoor, Carlo Heirman, Walter E.P. Beyer, Paul H.C. Eilers, Jurgen Corthals, Iman Padmos, Kris Thielemans, Albert D.M.E. Osterhaus, Patrick Lacor, Marchina E. van der Ende, Joeri L. AertsCarel A. van Baalen, Rob A. Gruters

Research output: Contribution to journal › Comment/debate

Original language	English
Pages (from-to)	88-89
Number of pages	2
Journal	Clinical Immunology
Volume	150
Issue number	1
DOIs	https://doi.org/10.1016/j.clim.2013.11.001
Publication status	Published - 1 Jan 2014

Keywords

hiv-1

Access to Document

10.1016/j.clim.2013.11.001

Cite this

Allard, S. D., De Keersmaecker, B., de Goede, A. L., Verschuren, E. J., Koetsveld, J., Reedijk, M. L., Wylock, C., De Bel, A. V., Vandeloo, J., Pistoor, F., Heirman, C., Beyer, W. E. P., Eilers, P. H. C., Corthals, J., Padmos, I., Thielemans, K., Osterhaus, A. D. M. E., Lacor, P., van der Ende, M. E., ... Gruters, R. A. (2014). Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]. Clinical Immunology, 150(1), 88-89. https://doi.org/10.1016/j.clim.2013.11.001

@article{3cb32d3dc56344fd9cb1c18735c83925,

title = "Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]",

keywords = "hiv-1",

author = "Allard, {Sabine D.} and {De Keersmaecker}, Brenda and {de Goede}, {Anna L.} and Verschuren, {Esther J.} and Jeanette Koetsveld and Reedijk, {Mariska L.} and Carolien Wylock and {De Bel}, {Annelies V.} and Judith Vandeloo and Frank Pistoor and Carlo Heirman and Beyer, {Walter E.P.} and Eilers, {Paul H.C.} and Jurgen Corthals and Iman Padmos and Kris Thielemans and Osterhaus, {Albert D.M.E.} and Patrick Lacor and {van der Ende}, {Marchina E.} and Aerts, {Joeri L.} and {van Baalen}, {Carel A.} and Gruters, {Rob A.}",

year = "2014",

month = jan,

day = "1",

doi = "10.1016/j.clim.2013.11.001",

language = "English",

volume = "150",

pages = "88--89",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

number = "1",

}

Allard, SD, De Keersmaecker, B, de Goede, AL, Verschuren, EJ, Koetsveld, J, Reedijk, ML, Wylock, C, De Bel, AV, Vandeloo, J, Pistoor, F, Heirman, C, Beyer, WEP, Eilers, PHC, Corthals, J, Padmos, I, Thielemans, K, Osterhaus, ADME, Lacor, P, van der Ende, ME, Aerts, JL, van Baalen, CA & Gruters, RA 2014, 'Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]', Clinical Immunology, vol. 150, no. 1, pp. 88-89. https://doi.org/10.1016/j.clim.2013.11.001

Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]. / Allard, Sabine D.; De Keersmaecker, Brenda; de Goede, Anna L. et al.
In: Clinical Immunology, Vol. 150, No. 1, 01.01.2014, p. 88-89.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

AU - Allard, Sabine D.

AU - De Keersmaecker, Brenda

AU - de Goede, Anna L.

AU - Verschuren, Esther J.

AU - Koetsveld, Jeanette

AU - Reedijk, Mariska L.

AU - Wylock, Carolien

AU - De Bel, Annelies V.

AU - Vandeloo, Judith

AU - Pistoor, Frank

AU - Heirman, Carlo

AU - Beyer, Walter E.P.

AU - Eilers, Paul H.C.

AU - Corthals, Jurgen

AU - Padmos, Iman

AU - Thielemans, Kris

AU - Osterhaus, Albert D.M.E.

AU - Lacor, Patrick

AU - van der Ende, Marchina E.

AU - Aerts, Joeri L.

AU - van Baalen, Carel A.

AU - Gruters, Rob A.

PY - 2014/1/1

Y1 - 2014/1/1

KW - hiv-1

UR - http://www.scopus.com/inward/record.url?scp=84890098439&partnerID=8YFLogxK

U2 - 10.1016/j.clim.2013.11.001

DO - 10.1016/j.clim.2013.11.001

M3 - Comment/debate

AN - SCOPUS:84890098439

SN - 1521-6616

VL - 150

SP - 88

EP - 89

JO - Clinical Immunology

JF - Clinical Immunology

IS - 1

ER -

Corrigendum to 'A phase I/IIa immunotherapy trial of HIV-1-infected patients with Tat, Rev and Nef expressing dendritic cells followed by treatment interruption' [Clin. Immunol. 142 (2012) 252-268]

Keywords

Access to Document

Other files and links

Cite this